Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 9 | 2017 | 262 | 1.440 |
Why?
|
| Electroencephalography | 3 | 2024 | 74 | 1.030 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2023 | 22 | 1.010 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 1084 | 0.840 |
Why?
|
| Memory Disorders | 2 | 2017 | 160 | 0.610 |
Why?
|
| Neural Pathways | 1 | 2017 | 65 | 0.560 |
Why?
|
| Temporal Lobe | 3 | 2023 | 69 | 0.480 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 25 | 0.460 |
Why?
|
| Alzheimer Disease | 5 | 2018 | 1962 | 0.420 |
Why?
|
| Epilepsy | 3 | 2018 | 56 | 0.410 |
Why?
|
| White Matter | 1 | 2014 | 123 | 0.400 |
Why?
|
| Parahippocampal Gyrus | 1 | 2011 | 6 | 0.370 |
Why?
|
| Amnesia | 2 | 2011 | 25 | 0.360 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 10 | 0.340 |
Why?
|
| Brain Mapping | 5 | 2016 | 153 | 0.340 |
Why?
|
| Atrophy | 5 | 2014 | 88 | 0.300 |
Why?
|
| Organ Size | 6 | 2014 | 103 | 0.280 |
Why?
|
| Entorhinal Cortex | 4 | 2012 | 36 | 0.270 |
Why?
|
| Nerve Fibers | 1 | 2006 | 12 | 0.270 |
Why?
|
| Aging | 4 | 2018 | 1429 | 0.260 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 155 | 0.250 |
Why?
|
| Memory | 4 | 2011 | 296 | 0.240 |
Why?
|
| Female | 17 | 2018 | 14273 | 0.240 |
Why?
|
| Humans | 19 | 2024 | 25692 | 0.230 |
Why?
|
| Male | 14 | 2018 | 13917 | 0.220 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 3 | 2018 | 10 | 0.200 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 4 | 0.190 |
Why?
|
| Potassium Channels | 2 | 2012 | 37 | 0.190 |
Why?
|
| Aged | 11 | 2018 | 8501 | 0.180 |
Why?
|
| Neuroimaging | 3 | 2018 | 115 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2012 | 151 | 0.180 |
Why?
|
| Channelopathies | 1 | 2018 | 5 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 6 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 37 | 0.150 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 30 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 45 | 0.150 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 2 | 0.140 |
Why?
|
| Adult | 5 | 2017 | 7336 | 0.140 |
Why?
|
| Brain Waves | 1 | 2016 | 5 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2016 | 46 | 0.140 |
Why?
|
| Brain | 3 | 2011 | 1560 | 0.130 |
Why?
|
| Young Adult | 5 | 2016 | 1855 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 46 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 69 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 118 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1689 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 163 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 190 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4459 | 0.110 |
Why?
|
| Functional Laterality | 3 | 2014 | 65 | 0.100 |
Why?
|
| Perforant Pathway | 1 | 2012 | 3 | 0.100 |
Why?
|
| Axons | 1 | 2012 | 26 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2011 | 16 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 36 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 84 | 0.090 |
Why?
|
| Biomarkers | 1 | 2014 | 554 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2018 | 1781 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 6 | 0.090 |
Why?
|
| Seizures | 2 | 2023 | 58 | 0.090 |
Why?
|
| Middle Aged | 8 | 2018 | 8403 | 0.090 |
Why?
|
| Frontal Lobe | 2 | 2011 | 69 | 0.080 |
Why?
|
| Neoplasms | 1 | 2010 | 224 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 48 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 412 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2005 | 34 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 372 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1300 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 532 | 0.070 |
Why?
|
| Cognition | 1 | 2014 | 1265 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2007 | 415 | 0.060 |
Why?
|
| Adolescent | 3 | 2016 | 2076 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2011 | 965 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2012 | 776 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 293 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3220 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2023 | 8 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 3510 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 443 | 0.050 |
Why?
|
| Child | 2 | 2016 | 1277 | 0.050 |
Why?
|
| Peroxins | 2 | 2012 | 2 | 0.050 |
Why?
|
| Protein Transport | 2 | 2012 | 29 | 0.050 |
Why?
|
| Algorithms | 1 | 2023 | 347 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 405 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3231 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 24 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 87 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 217 | 0.040 |
Why?
|
| Mice | 2 | 2012 | 1345 | 0.040 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 23 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 67 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 716 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 584 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 116 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 640 | 0.030 |
Why?
|
| Reference Values | 2 | 2005 | 183 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 93 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 217 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 646 | 0.020 |
Why?
|
| Tissue Embedding | 1 | 2012 | 4 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 5 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 21 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 19 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 49 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 49 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 112 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 12 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 495 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2011 | 75 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 36 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 284 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 649 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 57 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 207 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 664 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 403 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 1176 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 913 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 731 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 110 | 0.010 |
Why?
|